FDA Inspection 816379 — Washington Hospital Center Transfusion Service
The FDA completed an inspection of Washington Hospital Center Transfusion Service on Jan 28, 2013 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 28, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Washington, DC (United States)